The origin and impact of embryonic aneuploidy
Abstract
Despite the clinical importance of aneuploidy, surprisingly little is known concerning its impact during the earliest stages of human development. This study aimed to shed light on the genesis, progression, and survival of different types of chromosome anomaly from the fertilized oocyte through the final stage of preimplantation development (blastocyst). 2,204 oocytes and embryos were examined using comprehensive cytogenetic methodology. A diverse array of chromosome abnormalities was detected, including many forms never recorded later in development. Advancing female age was associated with dramatic increase in aneuploidy rate and complex chromosomal abnormalities. Anaphase lag and congression failure were found to be important malsegregation causing mechanisms in oogenesis and during the first few mitotic divisions. All abnormalities appeared to be tolerated until activation of the embryonic genome, after which some forms started to decline in frequency. However, many aneuploidies continued to have little impact, with affected embryos successfully reaching the blastocyst stage. Results from the direct analyses of female meiotic divisions and early embryonic stages suggest that chromosome errors present during preimplantation development have origins that are more varied than those seen in later pregnancy, raising the intriguing possibility that the source of aneuploidy might modulate impact on embryo viability. The results of this study also narrow the window of time for se…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Human embryos likely tolerate aneuploidy up to embryo genome activation.
“It is likely that human embryos tolerate aneuploidy up to embryo genome activation, given that even embryos with observed multipolar spindles continue to develop during early cleavage divisions (34).”
From Frequent loss of heterozygosity in CRISPR-Cas9–edited early human embryos (2021) · cites this paper as [34]
Cited by
Sorted by citations
Frequent loss of heterozygosity in CRISPR-Cas9–edited early human embryos
Alanis-Lobato, G., Zohren, J., McCarthy, A., Fogarty, N. M. E., Kubikova, N., Hardman, E., Greco, M., Wells, D., Turner, J. M. A., & Niakan, K. K. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004832117 · Cited by 234 · see citing works
Self-citationMorphological and cytogenetic assessment of cleavage and blastocyst stage embryos
Fragouli, E., Alfarawati, S., Spath, K., & Wells, D. (2014) · Molecular Human Reproduction · doi:10.1093/molehr/gat073 · Cited by 189 · see citing works
Self-citationAbsolute Risks of Obstetric Outcomes Risks by Maternal Age at First Birth: A Population-based Cohort
Schummers, L., Hutcheon, J. A., Hacker, M. R., VanderWeele, T. J., Williams, P. L., McElrath, T. F., & Hernandez-Diaz, S. (2018) · Epidemiology · doi:10.1097/ede.0000000000000818 · Cited by 96 · see citing works
Epigenetics in Turner syndrome
Álvarez-Nava, F., & Lanes, R. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0477-0 · Cited by 79 · see citing works
- Authors
- Fragouli, E., Alfarawati, S., Spath, K., Jaroudi, S., Sarasa, J., Enciso, M., & Wells, D.
- Affiliations
- University of Oxford (GB)
- Corresponding author
- Fragouli, Elpida
- Venue
- Human Genetics
- Published
- 2013-04-26
- Volume
- 132
- Issue
- 9
- Pages
- 1001-1013
- ISSN
- 0018-7348 (ISSN-L)
- 0340-6717
- 1432-1203
- OpenAlex
- W2058843560
- Cited by
- 290
- References
- 0
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 18 · 2023: 17 · 2022: 26 · 2021: 25 · 2020: 31 · 2019: 30 · 2018: 24 · 2017: 25 · 2016: 18 · 2015: 24 · 2014: 19 · 2013: 4
- FWCI
- 22.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Human Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute for Health and Care Research
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Biology and Fertility
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- embryonic aneuploidy, chromosomal abnormalities, preimplantation embryo development, oocyte meiosis, maternal age, embryo viability, blastocyst, zygotic genome activation, embryo selection
- MeSH terms
- Age Factors, Anaphase, Aneuploidy, Female, Humans, Oogenesis, Pregnancy, Chromosome Segregation, Cytogenetic Analysis, Embryonic Development, Comparative Genomic Hybridization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review